Literature DB >> 2524533

Activity of various glycopeptides against an inducibly vancomycin-resistant strain of Enterococcus faecium (D366).

D M Shlaes1, S Al-Obeid, J H Shlaes, R Williamson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2524533     DOI： 10.1093/infdis/159.6.1132

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  6 in total

1.  In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873.

Authors:  F Biavasco; R Lupidi; P E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

2.  Mechanism of resistance to vancomycin in Enterococcus faecium D366 and Enterococcus faecalis A256.

Authors:  S al-Obeid; E Collatz; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

3.  Enterococcal resistance to vancomycin and related cyclic glycopeptide antibiotics.

Authors:  D M Shlaes; B Binczewski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

Review 4.  Resistance to vancomycin and teicoplanin: an emerging clinical problem.

Authors:  A P Johnson; A H Uttley; N Woodford; R C George
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

5.  Activities of two new teicoplanin amide derivatives (MDL 62211 and MDL 62873) compared with activities of teicoplanin and vancomycin against 800 recent staphylococcal isolates from France and the United States.

Authors:  R N Jones; F W Goldstein; X Y Zhou
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

6.  In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates of Clostridium difficile.

Authors:  F Biavasco; E Manso; P E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.